Clinical significance of the DECAF score in acute exacerbations of chronic obstructive pulmonary disease
Eurasian Journal of Pulmonology · 2026
DOI: 10.14744/ejp.2026.46653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Pulmonology, 2026. Verfasst von Ayşe Çifci und 4 weiteren Autor:innen.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND AND AIM: The prognosis of chronic obstructive pulmonary disease (COPD) depends on the frequency and severity of exacerbations. The DECAF score (dyspnea, eosinopenia, consolidation, acidemia, and atrial fibrillation) is a cost-effective tool used to predict exacerbation outcomes. This study examines its relationship with six-month mortality following COPD exacerbations (ECOPD). METHODS: Patients (n=260) hospitalized at our center between December 15, 2021 and June 15, 2022 due to ECOPD were evaluated prospectively. Patients were classified into low-risk (DECAF score
Zitieren
APA
Çifci, A., Duyar, S. Ş., Kaymaz, D., Sönmez, Ö., & Düzgün, S. (2026). Clinical significance of the DECAF score in acute exacerbations of chronic obstructive pulmonary disease. Eurasian Journal of Pulmonology. https://doi.org/10.14744/ejp.2026.46653
Vancouver
Çifci A, Duyar SŞ, Kaymaz D, Sönmez Ö, Düzgün S. Clinical significance of the DECAF score in acute exacerbations of chronic obstructive pulmonary disease. Eurasian Journal of Pulmonology. 2026. doi:10.14744/ejp.2026.46653
BibTeX
@article{ifci2026,
author = {Çifci, Ayşe and Duyar, Sezgi Şahin and Kaymaz, Dicle and Sönmez, Özlem and Düzgün, Sevim},
title = {Clinical significance of the DECAF score in acute exacerbations of chronic obstructive pulmonary disease},
journal = {Eurasian Journal of Pulmonology},
year = {2026},
doi = {10.14744/ejp.2026.46653}
}
EUVIMED